Biomedical Engineering in ScandinaviaSemester Course

Week-Long Study Tour
Core Course Week Study Tour
Major Discipline(s)
Biology, Biomedicine / Biotechnology, Engineering
Core Course
Fall/Spring semester

Engineer tools for biomedical discovery. This course explores the design, development, and implementation of cutting-edge technologies instrumental in advancing the biomedical sciences. Featuring current developments in Stockholm and the Nordic region, the course incorporates Field Studies with real-life examples from academia and industry to explain, analyze, and evaluate engineering principles behind technological design. Topics may include medical devices, biomedical imaging, biomechanics, nanotechnologies, stem cell and tissue engineering, pharmaceutical engineering, health informatics, and omics. Through a collaborative project, you will distill your learnings from local researchers and industry partners while utilizing engineering principles to propose novel technologies within the field.

Related Discipline(s)

This course would also be of interest to the following discipline(s):
Chemistry / Biochemistry, Physics / Biophysics


Liv Egnell

DIS Stockholm Semester Faculty

Ph.D. in Biophysics, NTNU Norwegian University of Science and Technology (2021). M.Sc. in Biomedical Engineering, KTH Royal Institute of Technology (2014). B.Sc. in Biomedical Engineering, KTH Royal Institute of Technology (2014). B.Sc. in Engineering Physics, Chalmers University of Technology (2012). Currently coordinating clinical studies as Clinical Affairs Specialist at Getinge. Previous experience leading clinical operations in a Copenhagen-based medtech startup developing AI for radiology. With DIS since 2023.

Adam Darwich

DIS Stockholm Semester Faculty

Associate Professor in Health Systems Engineering in the Department of Biomedical Engineering and Health Systems at KTH. Ph.D. in Pharmaceutical Sciences, University of Manchester (2014). Research focus on modelling and simulation of systems and processes related to healthcare, health services, pharmaceutical development, and precision dosing. With DIS since 2021.